The Diabetes Visual Function Supplement Study (DiVFuSS)

• Published in: British journal of ophthalmology Vol. 100; no. 2; pp. 227 - 234
• Main Authors: Chous, A Paul, Richer, Stuart P, Gerson, Jeffry D, Kowluru, Renu A
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.02.2016; BMJ Publishing Group
• Subjects: Adult; Aged; Antioxidants - administration & dosage; C-Reactive Protein - metabolism; Clinical Science; Contrast Sensitivity - physiology; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - physiopathology; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - physiopathology; Diabetic Retinopathy - drug therapy; Diabetic Retinopathy - physiopathology; Dietary Supplements; Female; Glucose; Glycated Hemoglobin A - metabolism; Humans; Lipids - blood; Macular degeneration; Macular Pigment - metabolism; Male; Middle Aged; Phytotherapy; Prospective Studies; Studies; Tumor Necrosis Factor-alpha - blood; Vision Disorders - drug therapy; Vision Disorders - physiopathology; Visual Acuity - physiology; Visual Fields - physiology; Vitamin D - analogs & derivatives; Vitamin D - blood; Xanthophylls - administration & dosage; Macula; Field of vision; Retina; Clinical Trial; Colour vision

BackgroundDiabetes is known to affect visual function before onset of retinopathy (diabetic retinopathy (DR)). Protection of visual function may signal disruption of mechanisms underlying DR.MethodsThis was a 6-month randomised, controlled clinical trial of patients with type 1 and type 2 diabetes w...